CN1224717A - Quinoxaline-1,4-dioxide derivative and its synthesis - Google Patents

Quinoxaline-1,4-dioxide derivative and its synthesis Download PDF

Info

Publication number
CN1224717A
CN1224717A CN 98105030 CN98105030A CN1224717A CN 1224717 A CN1224717 A CN 1224717A CN 98105030 CN98105030 CN 98105030 CN 98105030 A CN98105030 A CN 98105030A CN 1224717 A CN1224717 A CN 1224717A
Authority
CN
China
Prior art keywords
group
compound
quinoxaline
formula
replace
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 98105030
Other languages
Chinese (zh)
Inventor
薛飞群
赵荣材
王玉春
徐忠赞
李剑勇
柳军席
李金善
严相林
杜小丽
张继瑜
苗小楼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lanzhou Institute of Animal Husbandry and Veterinary Medicine CAAS
Original Assignee
Lanzhou Institute of Animal Husbandry and Veterinary Medicine CAAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lanzhou Institute of Animal Husbandry and Veterinary Medicine CAAS filed Critical Lanzhou Institute of Animal Husbandry and Veterinary Medicine CAAS
Priority to CN 98105030 priority Critical patent/CN1224717A/en
Publication of CN1224717A publication Critical patent/CN1224717A/en
Pending legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to the synthesis and application of medicine, especially of one quinoxaline derivative. The derivative of the present invention is used as antimicrobial and growth promoting medicine and is synthesized by leading active substituent to the benzene ring of parent nucleus and changing the substitute in the second position of parent nucleus. The said compounds have expanded antimicrobial spectrum, lowered toxicity and increased antiseptic activity.

Description

Quinoxaline-1,4-dioxide derivative and synthetic method
The present invention relates to the synthetic and Application Areas of medicine.
In recent years, the antimicrobial drug for animals of external listing, as " olaquindox " of Bayer A.G (Bayer) development (Olaquindox), " mequidox " of Pfizer Inc. (Pfizer) development (Mequidox) etc. all has-anti-microbial activity of Ding, some other digestive tract diseases effects such as certain growth promoting function and prevention pig bloody flux.And all owing to toxicity is higher, in clinical treatment, be subjected to certain restriction, and, poison for poult especially and constantly take place because poisoning appears in the clinical use of bird in olaquindox.
The objective of the invention is can cause the generation of Resistant strain in view of the shared antimicrobial drug of people and animals, unfavorable to the protection in new drug kind work-ing life, and influence people's diseases prevention and treatment and HUMAN HEALTH and the broad spectrum antibiotic a kind of for animals studied.It is by the Dui quinoxaline-1, the research of 4-titanium dioxide class drug molecule, quantitative structure-activity relation, introducing substituent change on two of active substituent and the parent nucleus on the phenyl ring of its parent nucleus, the antimicrobial spectrum of this compounds is expanded, toxicity reduces, anti-microbial activity significantly increases, and some other pathogenic micro-organisms such as mycoplasma, chlamydozoan are had the obvious suppression effect.
Motif compound of the present invention can be represented by formula I:
Figure A9810503000051
Wherein: R 1For ketone group, ester group, carboxy and amide groups, oximido, hydrazone or fragrance replace ketone group;
R 2, R 3Be nitrogenous substituting group or heterocyclic substituents such as hydrogen, halogen, amino, nitro, nitroso-group, and R 2, R 3Be not hydrogen simultaneously;
R 4Be hydrogen, lower paraffin hydrocarbons, alkoxyl group or aromatic substituent;
This compound derivatives is as antibiotic and promotes growth medicine.
The derivative of formula I can be prepared with following method:
Method A:
A (ⅰ), substituted o nitroaniline and suitable oxygenant, as: reactions such as potassium bichromate, potassium permanganate, perchloric acid, hydrogen peroxide, hypochlorous acid, obtain replacing the benzo furazan, represent with the general formula II
Figure A9810503000061
Wherein: adjacent nitre aniline substituent is represented with the general formula III
Figure A9810503000062
R in the III formula 2, R 3Has R in the formula I 2, R 3The meaning that is had.This reaction is at suitable solvent, as alcohols, 1, reacts in 4-dioxane, the chloroform, and reaction is preferably under the alkaline environment to be carried out, and temperature, was stirred 1-12 hour to the solvent refluxing temperature by zero.
A (ⅱ), replace the benzo furazan and contain the compound that the methylene compound reaction obtains, represent with formula I
Figure A9810503000071
Wherein methylene compound comprises and contains methylene radical: the ketoxime that ketone, aldehyde, acid amides, oxime or fragrance replace.
Reaction is (promptly to be solvent at suitable solvent as containing the methylene radical fluid cpds, be again reactant) carry out under the appropriate catalyst, as reacting in Trimethylamine 99, triethylamine, diethylamine, pyridine, sodium hydroxide and some organic acid, to the solvent refluxing temperature, the time is 1-48 hour to temperature in room temperature.
Method B
B (ⅰ), benzo furazan as alcohol, ether, 1, with the compound reaction that contain " active replace group ", obtain replace benzo furazan in 4-dioxane, the chloroform at suitable solvent, represent with the general formula II
Figure A9810503000072
Temperature of reaction, stirred 1-24 hour to the solvent refluxing temperature from room temperature.Wherein " the active group that replaces " is R in the formula I 2, R 3The meaning that has.
B (ⅱ), replacement benzo furazan are carried out A (ⅱ) reaction.
Method C
C (ⅰ), make 2-formyl quinoxaline-1,4-dioxide and the compound reaction that contains " the active group that replaces " must replace 2-formyl quinoxaline-1, the 4-dioxide, and wherein " the active group that replaces " has R in the formula I 2, R 3The meaning that is had.
C (ⅱ), replacement 2-formyl quinoxaline-1,4-dioxide and " nucleophilic reagent " reaction, as: substituted-amino, hydroxyl, urea, hydrazine hydrate, thiocarbamide reaction, reaction is preferably in alkalescence as carrying out in Trimethylamine 99, triethylamine, pyridine or its mixture, optimum temperuture can change between the reflux temperature of solvent in room temperature, stirred 1-48 hour, wherein " nucleophilic reagent " has R in the formula I 2, R 3The meaning that has.
According to derivative preparation method of the present invention, in the following example, provide, the following examples are simply to provide in the mode that illustrates, but should not limit the scope of the invention by any way.
Method A
Embodiment 1,6-chloro-3-methyl-2-ethanoyl quinoxaline-1, the 4-dioxide
1.1,4-chloro-2-N-methyl-p-nitroaniline 34.5 g (0.20ml) add 100ml ethanol, 50ml methyl alcohol, heating for dissolving, add small amounts of sodium hydroxide therein, make alkalize, add the oxygenant potassium bichromate, until color by the red stain Huang, produce yellow mercury oxide, need time 1-4 hour, filter, the nitrogen gas stream drying, get 27.3g, productive rate 80%, 146 ℃ of fusing points.
1.2, the 6-chlorobenzene that produces in 1.1 and furazan added the 50ml methyl ethyl diketone add 3gNaOH, the heat production phenomenon is arranged, temperature raises at once, stirs 24 hours, there is yellow crystal to separate out, filters the nitrogen gas stream drying, alcohol or chloroform recrystallization get 21g, productive rate 52%, 165 ℃ of fusing points.
Embodiment 2,6-chloro-3-methyl-2-ethoxycarbonyl quinoxaline-1, the 4-dioxide
2.1,4-chloro-2-N-methyl-p-nitroaniline 34.5g (0.20ml), carry out among the embodiment 1 1.1 reactions, the chloro benzo furazan.
2.2, the chloro benzo furazan adds the 50ml methyl aceto acetate and NaOH makes alkalize, is heated to boiling, stirs 48 hours, has yellow crystal to produce, filtration, the nitrogen gas stream drying, alcohol or chloroform recrystallization get 21.2g, productive rate 47%, 159 ℃ of fusing points.
Method B
Embodiment 3,6-piperazine-quinoxaline-1s, the 4-dioxide
3.1, benzo furazan thermosol does in the methanol mixed solution, adds piperazine, stirs 24 hours, has yellow crystal to separate out, filtration drying.
3.2,6-piperazine-quinoxaline-1s, the 4-dioxide carry out A (ⅱ) react 6-piperazine-2-ethanoyl quinoxaline-1, the 4-dioxide.
Embodiment 4
According to embodiment 3, can synthesize following one group of compound according to method B:
R 1 R 2 R 3 R 4
Figure A9810503000091
-H -CH 3
Figure A9810503000092
-H -CH 3
Figure A9810503000093
-H -CH 3
Figure A9810503000094
-F -CH 3
Figure A9810503000095
-F -CH 3
Figure A9810503000096
-H -CH 3 -H -CH 3 -F -CH 3
Figure A9810503000099
-F -CH 3
Method C:
Embodiment 5
7-fluoro-6-chloro-3-methyl-2-methyl carbamoyl oxime based quinoxaline-1, the 4-dioxide
5.1,3-fluoro-4-chloro-2-N-methyl-p-nitroaniline 28.8g (0.2mol) thermosol is in 100ml ethanol and 50ml methyl alcohol, adds alkali and makes alkalize, adds KMnO again 4, color reddens immediately, up to its colour changed into yellow, has yellow crystal to produce, and adds water and is reflected at below 20 ℃, stirred 8 hours, and filtration, drying, ethyl alcohol recrystallization gets 3-fluoro-4-chlorobenzene and furazan 30.6g, productive rate 81%.
5.2,3-fluoro-4-chlorobenzene and furazan add the methyl ethyl diketone dissolving and add pyridine, stirred 48 hours, and the yellow crystal generation is arranged, filtration, dry, ethyl alcohol recrystallization, get 7-fluoro-6-chloro-3-methyl-2-acetyl quinoxaline-1, the 4-dioxide adds oxammonium hydrochloride with it, in acidity or alkaline environment, stirred 20 hours, temperature is controlled at room temperature, has crystallization to separate out, filtration, dry, ether recrystallization, get 7-fluoro-6-chloro-3-methyl-2-methyl carbamoyl oxime based quinoxaline-1, the 4-dioxide.
Embodiment 6
According to embodiment 5,, can synthesize following one group of compound according to method C
R 1 R 2 R 3 R 4
Figure A9810503000101
-CL -H -CH 3 -CL -H -H
Figure A9810503000103
-CL -H -CH 3
Figure A9810503000104
-CL -H -CH 3 -CL -H -CH 3
Figure A9810503000112
-CL -H -CH 3 -CL -H -CH 3
Figure A9810503000114
-CL -H -CH 3 -CL -H -CH 3
Pharmacologically active
1, anti-microbial activity
In the laboratory, adopt doubling dilution, to the livestock and poultry The main pathogenic fungi, make external bacteriostatic experiment and show the: quinoxaline-1, the has a broad antifungal spectrum of 4-dioxide novel derivative, toxicity is lower, its antimicrobial spectrum comprises gram-positive microorganism and Gram-negative bacteria, especially the inside and outside Gram-negative bacteria is had extremely strong anti-microbial activity, respond well for control digestive tube and respiratory tract infection, and to the good restraining effect of some other pathogenic micro-organism also tool.
2, growth promoting function
Clinical experiment shows that this compounds has the promotion growth of animal, improves food conversion ratio, and improves the effect of feeding effect.

Claims (2)

1, a kind of quinoxaline-1, the 4-dioxide derivative is characterized in that they represent with formula I:
Figure A9810503000021
Wherein:
R 1Be ketone group, ester group, carboxyl, amide group, oximido, hydrazone or fragrance replace ketone group;
R 2, R 3Be nitrogenous substituting group or heterocyclic substituents such as hydrogen, halogen, amino, nitro, nitroso-group, and R 2, R 1Be not hydrogen simultaneously;
R 4Be hydrogen, lower paraffin hydrocarbons, alkoxyl group or aromatic substituent;
This derivative is as antibiotic and promotes growth medicine.
2, a kind of quinoxaline-1, the synthetic method of 4-dioxide derivative is characterized in that it comprises:
Method A:
(ⅰ), replace adjacent nitre aniline and oxidant reaction, obtain replacing the benzo furazan, represent with the general formula II:
Figure A9810503000022
Wherein: adjacent nitre aniline substituent is represented with the general formula III:
R in the III formula 2, R 3Be nitrogenous substituting group or heterocyclic substituents such as hydrogen, halogen, amino, nitro, nitroso-group, and R 2, R 3Be not hydrogen simultaneously;
(ⅱ), making the general formula II replace the benzo furazan reacts with containing " methylene compound ", obtains compound and represent with formula I Wherein: " methylene compound " comprises and contains methylene radical: the ketoxime that ketone, aldehyde, acid, acid amides, oxime or fragrance replace;
Method B
(ⅰ), make benzo furazan and the compound reaction that contains " active substituent group ", obtain replacing the benzo furazan, represent with the general formula II
Figure A9810503000033
Wherein: " the active group that replaces " has R in the claim 1 2, R 3The meaning that is had;
(ⅱ) make the general formula II replace the benzo furazan and react, obtain compound and represent with formula I with containing " methylene compound "
Figure A9810503000041
Wherein: " methylene compound " comprises the ketoxime of the ketone, aldehyde, acid, acid amides, oxime or the fragrance replacement that contain methylene radical;
Method C
(ⅰ), make 2-formyl quinoxaline-1,4-dioxide and the compound reaction that contains " the active group that replaces "
Wherein: " the active group that replaces " has R in the claim 1 2, R 3The meaning that is had;
(ⅱ), make replacement 2-formyl quinoxaline-1,4-dioxide and " nucleophilic reagent " reaction
Wherein: " nucleophilic reagent " comprises R in the claim 1 1The substituent compound that is had.
CN 98105030 1998-01-24 1998-01-24 Quinoxaline-1,4-dioxide derivative and its synthesis Pending CN1224717A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 98105030 CN1224717A (en) 1998-01-24 1998-01-24 Quinoxaline-1,4-dioxide derivative and its synthesis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 98105030 CN1224717A (en) 1998-01-24 1998-01-24 Quinoxaline-1,4-dioxide derivative and its synthesis

Publications (1)

Publication Number Publication Date
CN1224717A true CN1224717A (en) 1999-08-04

Family

ID=5218650

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 98105030 Pending CN1224717A (en) 1998-01-24 1998-01-24 Quinoxaline-1,4-dioxide derivative and its synthesis

Country Status (1)

Country Link
CN (1) CN1224717A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103145631A (en) * 2013-03-18 2013-06-12 广州英赛特生物技术有限公司 Antibacterial derivative of quinoxaline-1,4-dioxide and application in animal production thereof
CN110551072A (en) * 2019-10-18 2019-12-10 华中农业大学 quinoxaline-N 1, N 4 -dioxide derivative with DNA topoisomerase activity inhibition function, preparation method and application
CN111171013A (en) * 2020-01-08 2020-05-19 华中农业大学 quinoxaline-N containing thiazolidone structure1,N4-dioxide derivatives, preparation method and application thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103145631A (en) * 2013-03-18 2013-06-12 广州英赛特生物技术有限公司 Antibacterial derivative of quinoxaline-1,4-dioxide and application in animal production thereof
CN103145631B (en) * 2013-03-18 2015-08-19 广州英赛特生物技术有限公司 Germ resistance quinoxaline-1, the derivative of 4-dioxide and the application in animal productiong thereof
CN110551072A (en) * 2019-10-18 2019-12-10 华中农业大学 quinoxaline-N 1, N 4 -dioxide derivative with DNA topoisomerase activity inhibition function, preparation method and application
CN111171013A (en) * 2020-01-08 2020-05-19 华中农业大学 quinoxaline-N containing thiazolidone structure1,N4-dioxide derivatives, preparation method and application thereof
CN111171013B (en) * 2020-01-08 2021-03-16 华中农业大学 quinoxaline-N containing thiazolidone structure1,N4-dioxide derivatives, preparation method and application thereof

Similar Documents

Publication Publication Date Title
Turan‐Zitouni et al. Synthesis of Some 1‐[(N, N‐Disubstituted thiocar bamoylthio) acetyl]‐3‐(2‐thienyl)‐5‐aryl‐2‐pyrazoline Derivatives and Investigation of Their Antibacterial and Antifungal Activities
US4599418A (en) Benzoquinolizine carboxylic acid derivatives, and process for preparation thereof
JPS59118774A (en) Substituted phenylsulfonyloxybenzimidazole carbamates and manufacture
CN1224717A (en) Quinoxaline-1,4-dioxide derivative and its synthesis
Sensi et al. Rifamycins. 1 XXXV. 2 Amides and hydrazides of rifamycin B3
CN112442084B (en) Preparation method of antibacterial drug intermediate
CN105646392A (en) 1,3,4-oxadiazole compounds containing oxime carboxylate and preparation method and application of 1,3,4-oxadiazole compounds containing oxime carboxylate
US4044130A (en) Compositions for the control of microorganisms
US3948913A (en) New 5-nitrofuryl derivatives
EP0060573B1 (en) Thiolic derivatives of erythromycin having therapeutic activity, process for their preparation and pharmaceutical compositions containing them
Jensen et al. Use of acetylacetone to prepare a prodrug of cycloserine
US3947441A (en) Substituted 2-amino-4-(hydroxyamino)-pyrimidines
US4593024A (en) Dihydroisoxazole compounds and anthelmintic use
OZAWA et al. Synthesis and antimicrobial activity of salicylanilide derivatives. II
CN112409410A (en) Application of silver catalyst in preparation of antibacterial intermediate
CN116730942B (en) 1,3, 4-Oxadiazole-2 (3H) -thioketone compound and preparation method and application thereof
US4036849A (en) 1-(Para-substituted-phenyl)-1H-tetrazoles
US20240217917A1 (en) Photolytically degradable compounds and methods
CN116730941B (en) 5-Phenyl-1, 3, 4-oxadiazole compound and preparation method and application thereof
RU2136679C1 (en) 2-amino-5,6,7,8-tetrahydroquinoline-3-carboxylic acid 5-nitrofurfurylidenehydrazide
RU2671573C1 (en) 2-[6-methyl-4-(thietan-3-yloxy)pyrimidin-2-ylthio]acetohydrazide of maleic acid having antimicrobial activity
US4038392A (en) 3-(heterocyclicthiomethyl) quinoxaline-1,4-dioxides
US3528971A (en) Cycloalkyl nitrofuryl nitrones
CN109232543A (en) A kind of fungicide and its application
CN112028854B (en) Benzothiazole phenylurea compounds and preparation and sterilization application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication